60
Participants
Start Date
November 29, 2016
Primary Completion Date
August 31, 2018
Study Completion Date
December 31, 2018
ART plus Chidamide
Chidamide will be administrated 10mg each time, twice a week, interval not less than 3 days for 12 weeks.Antiretroviral therapy will be kept during entire study.
ART plus Placebo
Placebo will be administrated 10mg each time, twice a week, interval not less than 3 days for 12 weeks.Antiretroviral therapy will be kept during entire study.
Department of Infectious Diseases, Tangdu Hospital, The Fourth Military Medical University, Xi'an
The First Affiliated Hospital of Guangxi Medical University, Nanning
Zhejiang University, Hangzhou
Collaborators (1)
Chipscreen Biosciences, Ltd.
INDUSTRY
Zhejiang University
OTHER
First Affiliated Hospital of Guangxi Medical University
OTHER
Tang-Du Hospital
OTHER